EUVIMEDEUVIMED entdecken
Open Access

Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease

Leon C D Smyth iD, Daan Verhaege iD, Elio Standen-Bloom iD, Yue Wu iD, Yiming Gan iD, Steffen E Storck iD, Pavle Boskovic iD, Benjamin A Plog iD, Tornike Mamuladze iD, Jose A Mazzitelli, Zhuoying Wang iD, Daniel D Lee iD und 8 weitere

Journal of Experimental Medicine · 02.02.2026 · 223 (2)

DOI: 10.1084/jem.20251860 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 02.12.2025. Verfasst von Leon C D Smyth und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloidosis, Cerebral Veins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, Cure Alzheimer's Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by the accumulation of extracellular aggregated amyloid beta, resulting from impaired waste clearance. We recently identified new cerebrospinal fluid (CSF) efflux structures termed arachnoid cuff exit (ACE) points and speculated that these may be impacted in AD, leading to impaired waste clearance function. Using 5XFAD mice, we found progressive amyloidosis of bridging veins at ACE points. Indeed, in 5XFAD mice, there is impaired CSF efflux to the dura mater, impaired CSF flow along bridging veins, and impaired blood flow through bridging veins. These observations suggest that ACE point amyloidosis plays a role in waste clearance dysfunction in AD. In postmortem human samples, we also found striking amyloidosis of the bridging veins of individuals with AD. Moreover, in human AD specimens, there was prominent bridging vein structural degeneration, indicating advanced pathology and stronger deficits in humans. We propose that bridging vein amyloidosis is an underrecognized pathophysiological correlate of AD that may impair CSF efflux, intracranial pressure, vascular reactivity, and vascular integrity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloidosisCerebral VeinsHumansAnimalsMiceMice, TransgenicMaleFemaleAgedAmyloid beta-PeptidesDisease Models, AnimalAged, 80 and over

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Center for Brain Immunology and Glia (BIG), Washington University School of Medicine , St. Louis, MO, USA.
  • Department of Physiology, Monash University, Clayton, Victoria, Australia.
  • Biomedicine Discovery Institute, Monash University , Clayton, Victoria, Australia.
  • Department of Biomedical Engineering, Danforth Campus, Washington University in St Louis, St. Louis, MO, USA.
  • Department of Mechanical Engineering, University of Rochester, Rochester, NY, USA.

ORCID-Profile: Leon C D Smyth, Daan Verhaege, Elio Standen-Bloom, Yue Wu, Yiming Gan, Steffen E Storck, Pavle Boskovic, Benjamin A Plog, Tornike Mamuladze, Zhuoying Wang, Daniel D Lee, Gwendalyn J Randolph, Antoine Drieu, Katherine E Schwetye, Song Hu, Daniel S Reich, Douglas H Kelley, Rupal I Mehta, Jonathan Kipnis

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Cure Alzheimer's Fund
  • National Institutes of Health/
  • National Institute on Aging
  • Cure Alzheimer’s Fund

Zitieren

APA

Smyth, L. C. D., Verhaege, D., Standen-Bloom, E., Wu, Y., Gan, Y., Storck, S. E., Boskovic, P., Plog, B. A., Mamuladze, T., Mazzitelli, J. A., Wang, Z., Lee, D. D., Randolph, G. J., Drieu, A., Schwetye, K. E., Hu, S., Reich, D. S., Kelley, D. H., Mehta, R. I., & Kipnis, J. (2026). Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease. Journal of Experimental Medicine, 223(2). https://doi.org/10.1084/jem.20251860

Vancouver

Smyth LCD, Verhaege D, Standen-Bloom E, Wu Y, Gan Y, Storck SE, et al. Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease. Journal of Experimental Medicine. 2026;223(2). doi:10.1084/jem.20251860

BibTeX
@article{Smyth2026,
  author = {Smyth, Leon C D and Verhaege, Daan and Standen-Bloom, Elio and Wu, Yue and Gan, Yiming and Storck, Steffen E and Boskovic, Pavle and Plog, Benjamin A and Mamuladze, Tornike and Mazzitelli, Jose A and Wang, Zhuoying and Lee, Daniel D and Randolph, Gwendalyn J and Drieu, Antoine and Schwetye, Katherine E and Hu, Song and Reich, Daniel S and Kelley, Douglas H and Mehta, Rupal I and Kipnis, Jonathan},
  title = {Amyloidosis of bridging veins is a pathologic feature of Alzheimer’s disease},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {2},
  doi = {10.1084/jem.20251860}
}
Kostenlos starten →